Radiation treatment planning with FDG, PSMA and FAPI in different tumors

Recent advancements in imaging, particularly [18F]FDG PET/CT and [18F]PSMA-1007 have improved the detection of distant metastases including involved lymph nodes, thus influencing staging accuracy and potentially treatment outcomes. PET-CT is therefore implemented in radiation treatment planning to evaluate its impact versus computed tomography (CT) alone on radiation target volumes for involved-site radiotherapy (IS-RT) in different tumor entities.

Fig. 1 demonstrates multiple small lymph node metastases in [18F]PSMA-1007 in a patient with a primary high risk prostate cancer. 

Cooperation with the CCU Clinical Cooperation Unit Radiation Therapy (Prof. Dr. Dr. Debus).

The image displays a series of six axial medical scans showing cross-sections of the pelvic region. Specific areas are highlighted, indicating regions of interest that may represent abnormalities or areas for further examination. The scans use various color gradients to denote different levels of intensity or activity.

Fig.1. F-18-PSMA-1007 primary high risk prostate cacer

Form

Form data is loaded ...